학술논문

Mailed Letter Versus Phone Call to Increase Diabetic-Related Retinopathy Screening Engagement by Patients in a Team-Based Primary Care Practice: Prospective, Single-Masked, Randomized Trial
Document Type
Academic Journal
Source
Journal of Medical Internet Research. January 11, 2023, Vol. 25 Issue 9735
Subject
Ontario
Canada
Language
English
ISSN
1439-4456
Abstract
Background Vision loss from diabetic-related retinopathy (DR) is preventable through regular screening. Objective The purpose of this study was to test different patient engagement approaches to expand a teleophthalmology program at a primary care clinic in the city of Toronto, Canada. Methods A teleophthalmology program was set up in a large, urban, academic, team-based primary care practice. Patients older than 18 years with type 1 or type 2 diabetes were randomized to one of the following 4 engagement strategies: phone call, mail, mail plus phone call, or usual care. Outreach was conducted by administrative staff within the clinic. The primary outcome was booking an appointment for DR screening. Results A total of 23 patients in the phone, 28 in the mail, 32 in the mail plus phone call, and 27 in the control (usual care) group were included in the analysis. After the intervention and after excluding patients who said they were screened, 88% (15/17) of patients in the phone, 11% (2/18) in the mail, and 100% (21/21) in the mail and phone group booked an appointment with the teleophthalmology program compared to 0% (0/12) in the control group. Phoning patients positively predicted patients booking a teleophthalmology appointment (P Conclusions Patient engagement to book DR screening via teleophthalmology in an urban, academic, team-based primary care practice using telephone calls was much more effective than patient engagement using letters or usual care. Practices that have access to a local DR screening program and have resources for such engagement strategies should consider using them as a means to improve their DR screening rates. Trial Registration ClinicalTrials.gov NCT03927859; https://clinicaltrials.gov/ct2/show/NCT03927859
Introduction Over 80 million people around the world suffer from diabetic-related retinopathy (DR), the leading cause of blindness for people between the ages of 25 and 74 years [1]. The [...]